Structure of Azetukalner
CAS No.: 1009344-33-5
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Azetukalner primarily shows potential in neuroprotection and heart disease treatment by activating or regulating the sodium-potassium ATPase signaling pathway. It can modulate neuronal excitability by affecting the ionic gradients across cell membranes, possibly for the treatment of neurodegenerative or cardiovascular diseases.
Synonyms: XEN1101
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1009344-33-5 |
Formula : | C23H29FN2O |
M.W : | 368.49 |
SMILES Code : | CC(C)(C)CC(NC1=C(C)C=C(N2CC3=C(C=C(F)C=C3)CC2)C=C1C)=O |
Synonyms : |
XEN1101
|
MDL No. : | N/A |
InChI Key : | FJNPZKZPWVVSON-UHFFFAOYSA-N |
Pubchem ID : | 24743936 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H315-H319 |
Precautionary Statements: | P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 |
Description |
KCNQ2/3 activator-1 serves as an activator of the Kv7.2/Kv7.3 (KCNQ2/3) potassium channel and holds promise in alleviating pain, a primary concern in medical treatment[1].
|
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT05718817 | Focal Epilepsy|Tonic-Clonic Se... More >>izures Less << | PHASE3 | ENROLLING_BY_INVITATION | 2025-09-28 | Clinical Trials, Inc, Little R... More >>ock, Arkansas, 72205, United States|UC Irvine Health, Orange, California, 92868, United States|Research Institute of Orlando, LLC, Orlando, Florida, 32806, United States|Panhandle Research & Medical Clinic, Pensacola, Florida, 10021, United States|Hawaii Pacific Neuroscience, Honolulu, Hawaii, 96817, United States|Consultants in Epilepsy and Neurology, Boise, Idaho, 83704, United States|Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States|Bluegrass Epilepsy Research, LLC, Lexington, Kentucky, 40504, United States|Kentucky Clinic, Lexington, Kentucky, 40536, United States|MMP Neurology, Scarborough, Maine, 04074, United States|Mid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland, 20817, United States|University of Michigan Hospitals, Ann Arbor, Michigan, 48109-2435, United States|Michigan State University, East Lansing, Michigan, 48824, United States|Cornwell Health (Spectrum Health Hospitals), Grand Rapids, Michigan, 49503, United States|Northeast Epilepsy Group, Hackensack, New Jersey, 07601, United States|Montefiiore Medical Center, Bronx, New York, 10467, United States|Dent Neurosciences Research Center, Buffalo, New York, 14226, United States|New York University Comprehensive Epilepsy Center, New York, New York, 10016, United States|Mount Sinai Health, New York, New York, 10029, United States|SUNY Upstate Medical University, Syracuse, New York, 13210, United States|Duke University, Durham, North Carolina, 27710, United States|Summa Health, Akron, Ohio, 44304, United States|Providence Neurological Specialities, Portland, Oregon, 97225, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|University of Utah Clinical Neurosciences Center, Salt Lake City, Utah, 84132, United States|Carilion Clinic, Roanoke, Virginia, 24013, United States|Sentara Neurology Specialists, Virginia Beach, Virginia, 23456, United States|University of Washington Main Hospital, Seattle, Washington, 10012, United States|Aurora St. Luke's Medical Center, Milwaukee, Wisconsin, 53215, United States|STAT Research S.A., Buenos Aires, C1023AAB, Argentina|Hospital De Alta Complejidad en Red El Cruce - Dr Nester Carlos Kirchner Servicio de Atencion Medica Integral Para la Communidad, Florencio Varela, 1888, Argentina|Sanatorio del SUR S.A., Tucumán, 4000, Argentina|Royal Prince Alfred Hospital, Camperdown, 2050, Australia|Austin Health Pharmacy Clinical Trials, Heidelberg, 3084, Australia|Southern Neurology, Kogarah, 2217, Australia|Alfred Hospital Neurology CT Dept of Neuroscience, Melbourne, 30004, Australia|The Royal Melbourne Hospital, Parkville, 3050, Australia|Westmead Hospital Dept. of Neurology Epilepsy Unit, Westmead, 2145, Australia|University Hospital Innsbruck, Innsbruck, 6020, Austria|Hospital for active treatmnt Puls AD Neurology Dpt, Blagoevgrad, 2700, Bulgaria|MHATNP St. Naum, Sofia, 1113, Bulgaria|Center for Neurologic Research, Lethbridge, Alberta, T1J 0N9, Canada|Centro de investigación Clinica UC, Santiago, 8330073, Chile|University Hospital Centre Zagreb, Zagreb, 10000, Croatia|Motol University Hospital, Prague, 150 06, Czechia|Forbeli s.r.o., Prague, 160 00, Czechia|Universit?tsklinikum, ZNN - Epilepsiezentrum Frankfurt Rhein-Main, Frankfurt, 60528, Germany|Universitaets-Und Rehabilitations Ulm (RKU), Ulm, 89081, Germany|Semmelweis Egyetem, Idegsebeszeti es Neurointervencios Klinika, Budapest, 1145, Hungary|Hadassah Medical Center (HMC), Jerusalem, 9112001, Israel|The Tel Aviv Sourasky Medical Center, Tel Aviv, 6423906, Israel|IRCCS Istituto delle Scienze Neurologiche Bologna, Bologna, 40139, Italy|Centrum Medyczne Neuromed, Bydgoszcz, 85-163, Poland|COPERNICUS Podmiot Leczniczy Sp. z o.o., Gdańsk, 80-803, Poland|NZOZ Neuromed M. i M., Lublin, 20-064, Poland|Twoja Przychodnia Nowosolskie Centrum Medyczne, Nowa Sól, 67-100, Poland|MTZ Clinical Research Powered by Pratia, Warsaw, 02-172, Poland|Centro Hospitalar Universitário de Coimbra (CHUC), Coimbra, 3000-075, Portugal|Hospital Senhora da Oliviera de Guimaraes, Guimar?es, 4835-044, Portugal|Unidade Local Saúde Matosinhos, Porto, 4464-513, Portugal|Centro Hospitalar de Entre o Douro e Vouga, Santa Maria Da Feira, 520-211, Portugal|Hospital Universitario Cruces, Baracaldo, 48903, Spain|Vall d'Hebron Hospital, Barcelona, 08035, Spain|Hospital Vithas La Milagrosa, Madrid, 28010, Spain|Hospital Ramón Y Cajal, Madrid, 28034, Spain|Hospital Ruber Internacional, Madrid, 28034, Spain|Hospital Clinico San Carlos, Madrid, 28040, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, 28040, Spain|Hospital Regional De Malaga, Málaga, 29010, Spain|Hospital La Fe, Valencia, 46026, Spain|Hospital Clinico Universitario de Valladolid, Valladolid, 47003, Spain|Queen Elizabeth Hospital Birmingham, Birmingham, B15 2TH, United Kingdom|University College London, London, WC1N 3BG, United Kingdom Less << |
NCT03796962 | Focal Epilepsy | PHASE2 | ACTIVE_NOT_RECRUITING | 2025-10-28 | University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35294, United States|Strada Patient Care Center, Mobile, Alabama, 36604, United States|Xenoscience, Inc., Phoenix, Arizona, 85004, United States|Clinical Trials, Inc., Little Rock, Arkansas, 72205, United States|Altman Clinical Translational Research Institute (ACTRI), La Jolla, California, 92037, United States|California Pacific Medical Center (CPMC) - Sutter Pacific Epilepsy Program, San Francisco, California, 94109, United States|University of Colorado Hospital Anschutz Outpatient Pavilion, Aurora, Colorado, 80045, United States|University of Florida Jacksonville, Jacksonville, Florida, 32209, United States|Mayo Clinic Florida, Jacksonville, Florida, 32224, United States|Visionary Investigators Network, Miami, Florida, 33133, United States|Don Clinical Research Center, Miami, Florida, 33136, United States|The Neurology Research Group, LLC., Miami, Florida, 33176, United States|Research Institute of Orlando, LLC, Orlando, Florida, 32806, United States|Medsol Clinical Research Center, Port Charlotte, Florida, 33952, United States|Tallahassee Neurological Clinic, Tallahassee, Florida, 32308, United States|University of South Florida, Tampa, Florida, 33606, United States|Georgia Neurology and Sleep Medicine Associate, Suwanee, Georgia, 30024, United States|Hawaii Pacific Neuroscience, Honolulu, Hawaii, 96817, United States|Consultants in Epilepsy and Neurology, PLLC, Boise, Idaho, 83702, United States|Northwestern Medical Group, Department of Neurology, Chicago, Illinois, 60611, United States|University of Kansas Medical Center, Kansas City, Kansas, 66160, United States|Bluegrass Epilepsy Research, Lexington, Kentucky, 40504, United States|Maine Medical Partners Neurology, Scarborough, Maine, 04074, United States|Mid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland, 20817, United States|Boston Neuro Research Center, South Dartmouth, Massachusetts, 02747, United States|Minneapolis Clinic of Neurology, Ltd., Golden Valley, Minnesota, 55422, United States|Minnesota Epilepsy Group, P. A., Saint Paul, Minnesota, 55102, United States|Northeast Regional Epilepsy Group, Hackensack, New Jersey, 07601, United States|Institute of Neurology and Neurosurgery at Saint Barnabas, Livingston, New Jersey, 07039, United States|Northeast Regional Epilepsy Group, Morristown, New Jersey, 07960, United States|Dent Neurosciences Research Center, Amherst, New York, 14226, United States|NYU Langone Medical Center/NYU School of Medicine, New York, New York, 10016, United States|Northwell Health - Lenox Hill, New York, New York, 10075, United States|SUNY Upstate Medical University Institute for Human Performance, Syracuse, New York, 13210, United States|Five Towns Neuroscience Research, Woodmere, New York, 11598, United States|Asheville Neurology Specialists, PA, Asheville, North Carolina, 28806, United States|UC Gardner Neuroscience Institute, Cincinnati, Ohio, 45219, United States|Miami Valley Hospital, Dayton, Ohio, 45409, United States|University of Toledo Medical Center, Toledo, Ohio, 43606, United States|Providence Neurological Specialties East, Portland, Oregon, 97213, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Thomas Jefferson University Comprehensive Epilepsy Center, Philadelphia, Pennsylvania, 19107, United States|Allegheny Neurological Associates, Pittsburgh, Pennsylvania, 15212, United States|Vanderbilt Epilepsy Clinic, Nashville, Tennessee, 37232, United States|Austin Epilepsy Care Center, Austin, Texas, 78758, United States|James W. Aston Ambulatory Care Center, Dallas, Texas, 75390, United States|The University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229-3900, United States|University of Utah Health Clinical Neurosciences Center, Salt Lake City, Utah, 84132, United States|University of Virginia, Charlottesville, Virginia, 22903, United States|Virginia Commonwealth University, Richmond, Virginia, 23219, United States|Carilion Neurology Clinic, Roanoke, Virginia, 24016, United States|Winchester Neurological Consultants, Winchester, Virginia, 22601, United States|UW Medicine Valle Medical Center, Renton, Washington, 98055, United States|University of Washington School of Medicine, Regional Epilepsy Center at Harborview Medical Center, Seattle, Washington, 98104, United States|Children's and Women's Health Centre of British Columbia (BC Children's Hospital), Vancouver, British Columbia, V6H 3V4, Canada|London Health Sciences Center, London, Ontario, N6A 5A5, Canada|University Health Network-Toronto Western Hospital, Toronto, Ontario, M5T 2S8, Canada|LLC Arensia Exploratory Medicine, Tbilisi, 0112, Georgia|Epilepsiezentrum Berlin-Brandenburg, Berlin, 10365, Germany|Bethel Epilepsy Centre, Bielefeld, 33617, Germany|Univ.-Klinik Bonn, Klinik und Poliklinik fur Epileptologie, Bonn, 53127, Germany|Universitatsklinikym Frankfurt, Frankfurt, 60528, Germany|Universitatsklinikum Freiburg, Neurozentrum/Epilepsiezentrum, Freiburg, 79106, Germany|University Hospital Munster (UKM), Muenster, 48149, Germany|Klinikum Osnabruck, Osnabrück, 49076, Germany|Krankenhaus Barmherzige Brueder Regensburg, Regensburg, 93049, Germany|University of Tubingen-Dept. of Neurology and Epileptology, Tübingen, 72076, Germany|IRCCS- Istituto delle Scienze Neurologiche, Bellaria Hospital, Bologna, 40139, Italy|Dipartimento Scienze Mediche e Chirurgiche, Universita Magna Graecia di Catanzaro, Catanzaro, 88100, Italy|Fondazione IRCCS Istituto Neurologico C. Besta, Milano, 20133, Italy|IRCCS Istituto Neurologico Nazionale C. Mondino, Pavia, 27100, Italy|Azienda Ospedaliera Universita' Pisana, Pisa, 56124, Italy|Azienda Ospedaliera "Bianchi-Melacrino-Morelle"di Reggio Calabria, Reggio Calabria, 89123, Italy|Policlinico di Roma Umberto I, Roma, 00185, Italy|PMSI Republican Clinical Hospital, ARENSIA Exploratory Medicine, Chisinau, 2025, Moldova, Republic of|Hospital Virgen Macarena, Sevilla, Andalusia, 41009, Spain|Centro de Neurologia Avanzada, Sevilla, Andalusia, 41013, Spain|Hospital Germans Trias I Pujol, Badalona, Barcelona, 08916, Spain|Clínica Universidad Navarra, Pamplona, Navarra, 31008, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Universitario Vall d'Hebron, Barcelona, 08035, Spain|Hospital Vithas La Salud, Granada, 18008, Spain|Hospital U. Ramón y Cajal, Madrid, 28034, Spain|Hospital Ruber Internacional, Madrid, 28036, Spain|Hospital U. Clínico San Carlos, Madrid, 28040, Spain|Hospital Universitario Fundacion Jimenez Diaz, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Regional Universitario de Málaga, Málaga, 29010, Spain|Hospital Universitario y Politécnico La Fe, Valencia, 46026, Spain|Hospital Clínico Universitario Valladolid, Valladolid, 47003, Spain|Medical Center of Limited Liability Company "Harmoniya Krasy", Kyiv, 01135, Ukraine|Institute of Neurological Sciences, Glasgow, Scotland, G514TF, United Kingdom|University Hospital of Wales, Cardiff, Wales, CF14 4XW, United Kingdom|King's College Hospital NHS Foundation Trust, London, SE5 9RS, United Kingdom|St. George's University Hospitals NHS Foundation Trust, London, SW17 0QT, United Kingdom Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.71mL 0.54mL 0.27mL |
13.57mL 2.71mL 1.36mL |
27.14mL 5.43mL 2.71mL |
Tags: Azetukalner | XEN1101 | Tetrahydroisoquinolines | Amides | Benzene Compounds | Potassium Channel | Organic Building Blocks | Membrane Transporter/Ion Channel | Heterocyclic Building Blocks | 1009344-33-5
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL